SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $230,540 | -8.3% | 8,362 | 0.0% | 0.02% | -10.7% |
| Q2 2023 | $251,362 | -10.9% | 8,362 | -29.6% | 0.03% | -15.2% |
| Q2 2020 | $282,000 | +36.9% | 11,876 | +91.0% | 0.03% | -10.8% |
| Q2 2019 | $206,000 | -41.0% | 6,217 | -37.5% | 0.04% | -45.6% |
| Q1 2019 | $349,000 | +42.4% | 9,946 | +34.9% | 0.07% | +25.9% |
| Q4 2018 | $245,000 | -17.5% | 7,374 | +48.5% | 0.05% | -14.3% |
| Q2 2018 | $297,000 | -37.3% | 4,966 | -52.0% | 0.06% | -42.7% |
| Q1 2018 | $474,000 | +107.9% | 10,342 | +81.1% | 0.11% | +96.4% |
| Q4 2017 | $228,000 | -18.3% | 5,712 | -11.7% | 0.06% | -13.8% |
| Q2 2017 | $279,000 | -34.7% | 6,470 | -52.5% | 0.06% | -32.3% |
| Q1 2017 | $427,000 | +43.3% | 13,630 | +15.4% | 0.10% | +31.5% |
| Q4 2016 | $298,000 | -23.6% | 11,807 | -25.1% | 0.07% | -18.0% |
| Q3 2016 | $390,000 | +64.6% | 15,756 | +35.2% | 0.09% | +64.8% |
| Q2 2016 | $237,000 | – | 11,657 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |